Share

Opko Health CEO on Cytochromas Acquisition

Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.
07:15
Mon, Jan 28 20136:15 PM EST